Fate Therapeutics, Inc. (FATE)

NASDAQ

$2.08

$+0.00

(+0.19%)

Pre-Market

Fate Therapeutics, Inc. (FATE) Live Price Chart

Last updated: ⁦2026-10-21 10:20:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Fate Therapeutics, Inc. (FATE) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $2.08, with a market capitalization of $222.87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.95 to $3.23. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$222.87M
Open	$2.08
Day's High	$121.16
Day's Low	$0.66
Previous Close	$2.06
Volume	6.00
Average Volume	1.62M
P/E Ratio	--
52-Week High	$3.23
52-Week Low	$0.95
Dividend Yield	--
Earnings Date	--

Fate Therapeutics, Inc. (FATE) Pre-Market Stock Price

Fate Therapeutics, Inc. (FATE) is trading at $2.08 in pre-market trading as of 2026-10-21 08:45:00, up 1.17% ($0.02) from the previous close of $2.06

Pre-market trading shows how investors are pricing FATE before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Fate Therapeutics, Inc. (FATE) 7-Day Stock Price Change

Over the past seven days, Fate Therapeutics, Inc. (FATE) moved from $2.13 to $2.08, representing a decline of 2.16% ($0.05).

The stock traded between $1.75 and $2.18 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 1.32 million shares, up versus the previous seven-day period, indicating higher trading activity.

FATE 52-Week Price Position

Position in Range: 49.7%

52W Low$0.95

52W High$3.23

FATE is currently trading at $2.08, placing it 49.7% of the way from its 52-week low of $0.95 to its 52-week high of $3.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Fate Therapeutics, Inc. (FATE)?

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Fate Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	161
Exchange	NASDAQ
Company Website	https://www.fatetherapeutics.com

How to Buy Fate Therapeutics, Inc. (FATE) Stock on MEXC

Eligible investors can buy real shares of Fate Therapeutics, Inc. (FATE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for FATE and Place Your Order

Open the RealStocks trading page and search for FATE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Fate Therapeutics, Inc. (FATE) stock price today?

Fate Therapeutics, Inc. (FATE) is currently trading at $ 2.08, up 1.17% ($0.02) from the previous close of $ 2.06. Intraday prices update in real time during regular trading hours.

2.Is FATE stock going up or down today?

As of 2026-10-21 08:45:00, FATE is trading at $ 2.08, up 1.17% ($0.02) from its previous close of $ 2.06. The stock has traded between $ 0.66 and $ 121.16 during today’s regular session. Past price movements do not guarantee future results.

3.What is FATE pre-market price?

As of 2026-10-21 08:45:00, FATE is trading at $ 2.08 in pre-market trading, up 1.17% ($0.02) from the previous close of $ 2.06. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is FATE after-hours price?

As of 2026-10-21 08:45:00, FATE is trading at $ 2.08 in after-hours trading, up 0.97% ($0.02) from the regular-session close of $ 2.06. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is FATE stock trading now?

FATE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does FATE sit relative to its 52-week high and low?

Over the past 52 weeks, FATE has traded between a low of $ 0.95 and a high of $ 3.23. At $ 2.08, the stock is positioned 49.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Fate Therapeutics, Inc. in?

Fate Therapeutics, Inc. (FATE) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Fate Therapeutics, Inc.'s market capitalization and where is it listed?

Fate Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 222.87M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is FATE valued in terms of P/E ratio and EPS?

FATE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.05. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Fate Therapeutics, Inc. pay a dividend?

Fate Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.